Federal funding analysis
Reported transaction obligations
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 9 of 9 selected awards have dated, valued transactions.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $171.0K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $292.9K |
| Change | $-121.9K |
| Growth | -41.6%Why this funding changeNet obligations in equal-length adjacent periods. ($171,031.89 − $292,948.49) ÷ $292,948.49 × 100 = -41.62%
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Negative obligation adjustments can produce a decline below −100%. |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $1.4M | 2 |
| Department of Veterans Affairs | $553.6K | 7 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIAID | $1.4M | 2 |
| 249-NETWORK CONTRACT OFFICE 9 (36C249) | $378.1K | 4 |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | $175.4K | 3 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $1.4M | 2 |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $553.6K | 7 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.4M | 2 |
| 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $294.3K | 5 |
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $259.3K | 2 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $1.7M | 4 |
| 36C26222A0042 | $175.4K | 3 |
| 36C24926A0032 | $118.8K | 1 |
| 36C24924D0034 | $-3 | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| SMALL BUSINESS SET ASIDE - TOTAL | $1.4M | 2 |
| NO SET ASIDE USED. | $553.6K | 6 |
| Unclassified | $-3 | 1 |